Reach Us +1-504-608-2390
Defining The Early In Vivo Immune Response After Pulmonary Aspergillus Challenge Under Different Immune Suppressive Regimens | 19733
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference and Exhibition on Clinical & Cellular Immunology

Natarajaswamy Kalleda, Jorge Amich, Katharina Mattenheimer, Katja Ottm?ller, Ana-Laura Jord?n-Garrote1,Christian Brede, Marcel M?nstermann, Andreas Brandl, Hermann Einsele and Andreas Beilhack
Accepted Abstracts: J Clin Cell Immunol
DOI: 10.4172/2155-9899.S1.019
Background: The number of patients with immune suppression is steadily increasing due to various clinical therapies that require administration of immunosuppressive drugs as it is the case for patients undergoing allogenic hematopoietic stem cell or solid organ transplantation and patients with autoimmune conditions. Other disease conditions such as cancer, retroviral infections and genetic immune disorders also compromise the immune system. Fungal infections with the invasive mold Aspergillus fumigatus cause high morbidity and mortality in these clinical situations. The degree of immune suppression influences the severity of A. fumigatus infections. Furthermore, how virulence factors impact the immune response and consequently the outcome of infection remains elusive. Therefore, a better understanding of immune cell responses in various degrees of immune suppressive states following infection with virulent and attenuated A. fumigatus strains is required. Methods: To investigate the immune cell response under different immune suppressive regimens, we employed corticosteroid treated and cyclophosphamide treated leukopenic mouse models of invasive aspergillosis. We challenged immune competent, corticosteroid treated and leucopenic mice with 106 A. fumigatus virulent wild type or avirulent melanin layer deficient pksP mutant conidia. The immune cell recruitment in post-infection early and late time points (4h, 16h and 40h) was quantified using FACS analysis and histology. We utilized dynamic in situ multi-photon microscopy to corroborate our findings and to visualize the dynamic interactions between eGFP labeled immune cells and growing td tomato transgenic A. fumigatus in the lung under ex vivo conditions. Results and conclusion: Innate and adaptive immune cell populations significantly decreased after corticosteroid treatment. Infection of these mice with A. fumigatus wild type conidia resulted in a significant early (4 h) recruitment of neutrophils, alveolar macrophages, conventional macrophages, monocytes and eosinophils. However, at 16 h and 40 h after infection, immune cells decreased below steady state levels. In the leukopenic model, most of the immune cells disappeared from the lungs. However, at 4h after A. fumigatus infection reduced, but significant numbers of neutrophils, macrophages and monocytes were recruited to the lungs. In contrast to the corticosteroid model, the neutrophil recruitment persisted even at 16 h and 40 h after infection in leukopenic mice, even if immune cells decreased below the steady state levels. There was no significant recruitment of DCs, NK- and T cell subpopulations in both models. Surprisingly, the immune cell recruitment did not differ after infection with WT or the avirulent pksP conidia after 4h and 16h.This data suggest that the lack of melanin in pksP A. fumigatus mutants does not impact immune cell recruitment, but rather acts via suppression of reactive oxygen intermediates produced by immune cells. Taken together, these results demonstrated that myeloid cells are crucial for defense against A. fumigatus infections under immune suppression conditions.
Natarajaswamy Kalleda completed his Masters in biotechnology from Osmania University, Hyderabad, India. He worked as an ICMR-Senior Research Fellow in University of Delhi for couple of years and at present he is working in Wuerzburg University Hospital, Wuerzburg, Germany. He has background in molecular biology and immunology of fungal infections.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version